While elevated TGF-β levels in brain tissue and cerebrospinal fluid (CSF) have been observed in Alzheimer's disease patients [78, 79], the impairment of TGF-β signaling in neurons is postulated to be a standard feature of AD [80]. This evidence concerns the gene TGFB1 and early-onset autosomal dominant Alzheimer disease.